Search research articles
Contact Us
Filters
Showing results (241-250 of 273) with videos related to
Page
of 28
Sort By:
The Oncologist
|
July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
Nicole A Carreau, Orrin Pail, Philippe Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Blood Advances
|
November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Reid W Merryman, Robert A Redd, Eleanor Taranto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood Advances
|
March 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy
Ran Xu, Gongwei Wu, Siobhan Rice, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Blood
|
January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Reid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.
The Journal of Clinical Investigation
|
August 6, 2013
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E Burkhardt, Ursula Hainz, Kristen Stevenson, et al.
The Oncologist
|
April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 273) with videos related to
Sort By:
Page
of 28
The Oncologist
|
July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
Nicole A Carreau, Orrin Pail, Philippe Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Blood Advances
|
November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Reid W Merryman, Robert A Redd, Eleanor Taranto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood Advances
|
March 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy
Ran Xu, Gongwei Wu, Siobhan Rice, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Blood
|
January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Reid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.
The Journal of Clinical Investigation
|
August 6, 2013
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E Burkhardt, Ursula Hainz, Kristen Stevenson, et al.
The Oncologist
|
April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
Page
of 28